Auto-antibodies against apolipoprotein A1 may neutralize the cardioprotective effect of the HDL complex, causing cardiovascular disease in SLE patients with anti-apolipoprotein A1 antibodies (136, 150). This evidence concerns the gene APOA1 and cardiovascular disorder.